| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2013/03/06 | 02 : 38 | Zacks | Allergan Reaches 52-Week High - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/05 | 01 : 30 | Zacks | Allergan - MAP Acquisition Update - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/02 | 07 : 23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/02 | 07 : 23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/02 | 07 : 23 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/02 | 07 : 21 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/02 | 06 : 01 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/02 | 05 : 54 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/02 | 05 : 54 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/03/01 | 23 : 00 | Business Wire | Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc... | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/15 | 04 : 11 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/15 | 03 : 48 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/13 | 03 : 14 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/12 | 07 : 19 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/12 | 04 : 59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/12 | 03 : 56 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/12 | 03 : 56 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/09 | 05 : 52 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/09 | 04 : 15 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/09 | 03 : 37 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/08 | 06 : 59 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/07 | 23 : 00 | Business Wire | Allergan, Inc. & MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Per... | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/06 | 04 : 22 | Dow Jones News | UPDATE: Strong Botox Sales Help Lift Allergan's Profits 16% | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/06 | 01 : 28 | Zacks | AGN Earnings Miss but Guidance Tops - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/06 | 00 : 00 | Dow Jones News | Allergan 4th-Quarter Profit Rose 16% Amid Growing Revenue, Fewer Charges | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/05 | 08 : 08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/02 | 03 : 08 | GlobeNewswire Inc. | The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceut | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/02 | 01 : 50 | Zacks | Update on AGN's Acquisition of MAP - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/01 | 06 : 20 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 2013/02/01 | 06 : 01 | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |